Accessibility Menu
Roche Holding AG logo

Roche Holding AG(OTC) RHHBY

Current Price$54.70
Market Cap$301.47BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1992)+2,944%
5 Year+37%
1 Year+36%
1 Month+7%
Roche Holding AG last closing stock price
MetricPriceDate
Last closeUSD 54.702026-07-24
Roche Holding AG stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+6.01%USD 51.602026-07-17
1 month+6.77%USD 51.232026-06-24
3 month+5.93%USD 51.642026-04-24
Year to date+9.33%USD 50.032025-12-31
1 year+36.06%USD 40.202025-07-24
3 year+54.38%USD 35.432023-07-25
5 year+37.35%USD 39.832021-07-23
Since inception+2,944.38%USD 1.801992-08-07

Roche Holding AG Financials at a Glance

Market Cap

$301.47BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CHF 108.90B

Net Income (TTM)

CHF 18.17B

EPS (TTM)

$2.40

P/E Ratio

22.58

Dividend

$1.55

Beta (Volatility)

0.39 (Low)

Price

$54.70

Volume

3,511,789

Open

$54.48

Previous Close

$54.70

Daily Range

$54.06 - $54.84

52-Week Range

$37.51 - $60.85

Estimated Earnings Date

Jul 23, 2026

RHHBY News

Blue poker chips with investment related imagery in the background

Best Blue Chip ETFs to Buy in 2026

Rachel WarrenApr 17, 2026
drug development pharmaceutical pharma research researchers doctors

Pharmaceutical tariffs: Which countries does the U.S. import the most from?

Jack CaporalApr 2, 2026
growing your money, coins, dividends, time

How to Invest in Vanguard International High Dividend Yield ETF (VYMI)

Tony DongFeb 27, 2026
Dividends blackboard sketch doodle

How to Invest in Schwab International Dividend Equity ETF (SCHY)

Tony DongFeb 27, 2026
Scientist in lab coat studies a test tube of fluid while looking at a strand of DNA on a computer screen

Why Roche Holding Stock Popped Today

Rich SmithNov 10, 2025
person-doctors-office-treatment.jpg

How AI Is Used in Healthcare

Jeremy BowmanMay 26, 2025
Medical professional with hand on head

Why Roche Holdings Stock Withered on Wednesday

Eric VolkmanSep 11, 2024
Person standing on a scale.

Novo Nordisk and Eli Lilly Could Have a Big Rival in the GLP-1 Market in a Few Years

David Jagielski, CPAAug 18, 2024
Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Roche Holding AG

Roche Holding AG is a leading global healthcare company focused on pharmaceuticals and diagnostics. With a strong international presence, Roche develops innovative treatments across various medical fields, including oncology, immunology, and infectious diseases.

Products and Services
  • Pharmaceuticals targeting oncology, neuroscience, and immunology
  • Diagnostic tests for diseases like cancer, diabetes, and Covid-19
  • Essential diagnostic instruments and reagents
Growth Outlook
  • Strong pipeline with multiple new drug approvals anticipated
  • Continued expansion in emerging markets driving revenue growth
  • Investment in R&D expected to enhance product offerings
Financial Highlights
  • Q4 2025 revenue of 30.32 billion CHF, reflecting robust demand
  • TTM net profit margin of 20.94%, indicating strong profitability
  • Dividend yield of 2.93%, appealing for income-focused investors
Roche Holding AG has established itself as a formidable player in the healthcare sector, leveraging its extensive research capabilities and innovative product offerings. The company's commitment to R&D is evident in its strong pipeline, which is expected to yield new drug approvals and enhance its market position. The growth outlook remains positive, particularly in emerging markets where healthcare needs are expanding. Recent financial performance highlights a solid revenue base and strong profitability metrics, making Roche an attractive option for potential investors seeking exposure to the healthcare industry.
AI Generated • Jul 19, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

112,774

CEO

Thomas Schinecker, PhD

Website

www.roche.com

Headquarters

Basel, BS 4070, CH

RHHBY Financials

Key Financial Metrics (TTM)

Gross Margin

73.32%

Operating Margin

31.92%

Net Income Margin

20.25%

Return on Equity

37.12%

Return on Capital

27.56%

Return on Assets

12.57%

Earnings Yield

4.43%

Dividend Yield

2.83%

Payout Ratio

72.34%

Stock Overview

Market Cap

$301.47BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

5.51B

Volume

3.51M

Avg. Volume

2.14M

Financials (TTM)

Gross Profit

CHF 79.49B

Operating Income

CHF 26.20B

EBITDA

CHF 37.44B

Operating Cash Flow

CHF 36.73B

Capital Expenditure

-CHF 7.14B

Free Cash Flow

CHF 29.60B

Cash & ST Invst.

CHF 9.70B

Total Debt

CHF 31.69B

Roche Holding AG Performance Analysis

Roche Holding AG annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CHF 66,258,309,430-3.5%
20232023-12-31CHF 65,337,879,703-1.4%
20242024-12-31CHF 68,692,208,3065.1%
20252025-12-31CHF 74,072,268,7687.8%
Roche Holding AG sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-312.9%
Q22025-06-30-49.7%
Q42025-12-3190.4%
Q22026-06-302.3%
Roche Holding AG annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CHF 2.03-8.2%
20232023-12-31CHF 1.99-2.1%
20242024-12-31CHF 1.46-26.4%
20252025-12-31CHF 2.4164.8%
Roche Holding AG sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-67.7%
Q22025-06-3083.3%
Q42025-12-3145.7%
Q22026-06-3029.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CHF 31.02B

+0.8%

Gross Profit

CHF 22.86B

-1.8%

Gross Margin

73.72%

N/A

Market Cap

$301.47BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.92M

N/A

Employees

103,249

N/A

Net Income

CHF 7.02B

+12.2%

EBITDA

CHF 9.64B

-8.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CHF 9.70B

+10.0%

Total Debt

CHF 31.69B

-12.4%

Accounts Receivable

CHF 13.30B

+9.2%

Inventory

CHF 8.07B

+1.5%

Long Term Debt

CHF 25.13B

-16.7%

Short Term Debt

CHF 6.56B

+8.9%

Return on Assets

12.57%

N/A

Return on Invested Capital

28.05%

N/A

Free Cash Flow

CHF 5.72B

-7.6%

Operating Cash Flow

CHF 7.32B

-7.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NVSEFNovartis AG
$154.47+0.00%
NONOFNovo Nordisk A/S
$49.70+2.22%
SNYNFSanofi
$88.28+0.00%
GLAXFGSK plc
$25.31+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
SOFISoFi Technologies
$16.46-0.01%

Questions About RHHBY

What is the current price of Roche Holding AG?

Roche Holding AG is trading at $54.70 per share.

What is the 52-week range for Roche Holding AG?

Over the past 52 weeks, Roche Holding AG has traded between $37.51 and $60.85.

How much debt does Roche Holding AG have?

As of the most recent reporting period, Roche Holding AG reported total debt of CHF 41.89B.

How much cash does Roche Holding AG have on hand?

Roche Holding AG reported CHF 7.05B in cash and cash equivalents in its most recent financial results.

What is Roche Holding AG’s dividend yield?

Roche Holding AG currently has a dividend yield of 2.83%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services